TPTX
Turning Point Therapeutics, Inc. Common Stock
TPTX
TPTX
Delisted
TPTX was delisted on the 16th of August, 2022.
166 hedge funds and large institutions have $3.45B invested in Turning Point Therapeutics, Inc. Common Stock in 2020 Q3 according to their latest regulatory filings, with 23 funds opening new positions, 79 increasing their positions, 44 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
5% more funds holding
Funds holding: 158 → 166 (+8)
1% less call options, than puts
Call options by funds: $1.75M | Put options by funds: $1.77M
Holders
166
Holding in Top 10
5
Calls
$1.75M
Puts
$1.77M
Top Buyers
1 | +$109M | |
2 | +$36M | |
3 | +$14.6M | |
4 |
NIP
Nicholas Investment Partners
Rancho Santa Fe,
California
|
+$13.3M |
5 |
State Street
Boston,
Massachusetts
|
+$11.4M |
Top Sellers
1 | -$32.6M | |
2 | -$25.8M | |
3 | -$12.2M | |
4 |
FLAM
First Light Asset Management
Edina,
Minnesota
|
-$12.1M |
5 |
N
Natixis
Paris,
France
|
-$8.38M |